Transcat, Inc. (NASDAQ:TRNS) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Transcat, Inc. (NASDAQ:TRNS) has received a consensus rating of “Moderate Buy” from the eight analysts that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, three have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $110.25.

TRNS has been the topic of a number of research analyst reports. Zacks Research raised Transcat from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 7th. HC Wainwright reaffirmed a “buy” rating and set a $116.00 target price on shares of Transcat in a research note on Friday, August 22nd. Northland Capmk raised shares of Transcat from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 23rd. Northland Securities set a $95.00 price target on shares of Transcat in a research note on Thursday, October 23rd. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research report on Monday, December 1st.

Institutional Investors Weigh In On Transcat

A number of large investors have recently made changes to their positions in TRNS. State of Alaska Department of Revenue purchased a new position in Transcat during the third quarter worth approximately $40,000. Lazard Asset Management LLC acquired a new stake in shares of Transcat in the 2nd quarter worth $54,000. Parkside Financial Bank & Trust purchased a new position in shares of Transcat during the 2nd quarter worth $79,000. Quantbot Technologies LP acquired a new position in shares of Transcat during the 1st quarter valued at about $76,000. Finally, PNC Financial Services Group Inc. grew its holdings in shares of Transcat by 1,118.2% in the second quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company’s stock valued at $92,000 after purchasing an additional 984 shares during the period. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Transcat Stock Performance

NASDAQ TRNS opened at $53.84 on Friday. The stock has a market capitalization of $502.33 million, a price-to-earnings ratio of 44.13 and a beta of 0.79. The stock has a 50-day moving average of $64.31 and a 200 day moving average of $75.68. The company has a current ratio of 2.43, a quick ratio of 2.06 and a debt-to-equity ratio of 0.38. Transcat has a twelve month low of $52.06 and a twelve month high of $111.45.

Transcat (NASDAQ:TRNS) last announced its earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). The business had revenue of $82.27 million for the quarter, compared to analysts’ expectations of $79.51 million. Transcat had a net margin of 3.75% and a return on equity of 6.81%. Sell-side analysts anticipate that Transcat will post 2.3 EPS for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.